“…This is particularly relevant also for the psychosomatic and mental health domain (Gureje et al, 2015), where treatments are known to be markedly underprovided on a global scale (see worldwide treatment gap in mental health; Kohn et al, 2004;WHO, 2008;Evans-Lacko et al, 2017) and where chronicity is common (Costello et al, 2002;Brandon et al, 2007;Koob and Le Moal, 2008;WHO, 2008). Among traditional medical systems currently investigated for mental health, especially the Amazonian tradition and its psychoactive ayahuasca brew (Banisteriopsis caapi and varying admixture plants; Riba et al, 2003;McKenna, 2004) have recently become the center of scientific attention across the globe (Feeney et al, 2018;Hamill et al, 2018;Labate and Cavnar, 2018). Clinical research in this context has been burgeoning over the last years, alongside research on other psychoactive substances (see also "psychedelic-assisted therapies"; Tupper et al, 2015;Johnson et al, 2019), with growing evidence showing ayahuasca to benefit affective disorders, substance use, anxiety disorders, and other conditions (Thomas et al, 2013;Labate and Cavnar, 2014;Osorio Fde et al, 2015;dos Santos et al, 2016;Nunes et al, 2016;Coe and McKenna, 2017;Domıńguez-Clavéet al, 2018;Palhano-Fontes et al, 2018;Renelli et al, 2018;Berlowitz et al, 2019).…”